VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SMG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SMGThe Scotts Miracle-Gro Company
$62.55$3.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSMGFinancials

The Scotts Miracle-Gro Company (SMG) Income Statement

30Y historyFree accessUpdated daily

Revenue contracted 3.9% in fiscal 2026 with Q3 gross margin improving to 31.2% from 29.5% a year earlier, yet operating leverage remains extreme as Q2 2026's 28.2% operating margin swung to -38.7% in Q4 2025.

Income StatementBalance SheetCash FlowRatios

SMG Income Statement

Annual statement

SMG Income Statement

The Scotts Miracle-Gro Company (SMG) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricSep'26Sep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98Sep'97
Sales/Revenue3.29B3.41B3.55B3.55B3.92B4.92B4.13B3.16B2.66B2.64B2.84B3.02B2.84B2.82B2.83B2.84B3.14B2.98B2.98B2.87B2.7B2.37B2.04B1.91B1.76B1.75B1.76B1.65B1.11B900.8M
Revenue Growth %-3.64%-3.93%0.04%-9.5%-20.32%19.2%30.91%18.5%0.81%-6.84%-5.98%6.17%0.88%-0.34%-0.34%-9.69%5.34%-0.04%3.83%6.48%13.84%16.26%6.69%8.49%0.74%-0.94%7.04%48.1%23.56%19.8%
Cost of Goods Sold2.23B2.37B2.7B2.89B3.05B3.46B2.78B2.14B1.8B1.67B1.84B1.95B1.81B1.83B1.86B1.83B1.99B1.92B2.04B1.87B1.74B1.51B1.27B1.21B1.12B1.09B1.01B954.3M690.1M553.4M
COGS % of Revenue67.68%69.41%76.06%81.49%77.76%70.17%67.4%67.69%67.54%63.19%64.9%64.7%63.7%65.12%65.98%64.63%63.46%64.52%68.49%65.02%64.56%63.7%62.2%63.36%63.84%62.31%57.32%57.9%62%61.43%
Gross Profit1.06B1.04B850.5M657.3M872.9M1.47B1.35B1.02B864.6M972.6M995.4M1.06B1.03B982.4M961.3M1B1.15B1.06B939.6M1B955.9M860.1M770.3M699.9M636.6M658.7M753M694M422.9M347.4M
Gross Margin %32.32%30.59%23.94%18.51%22.24%29.83%32.6%32.31%32.46%36.81%35.1%35.3%36.3%34.88%34.02%35.37%36.54%35.48%31.51%34.98%35.44%36.3%37.8%36.64%36.16%37.69%42.68%42.1%38%38.57%
Gross Profit Growth %1.8%22.77%29.39%-24.7%-40.58%9.06%32.11%17.93%-11.1%-2.29%-6.53%3.25%4.99%2.19%-4.16%-12.58%8.48%12.56%-6.46%5.08%11.14%11.66%10.06%9.94%-3.36%-12.52%8.5%64.11%21.73%-3.04%
Operating Expenses656.3M685.6M641.7M831.7M1.31B746M761.8M602.6M540.1M550.9M597.1M698.4M680.5M661.1M713.5M698.2M744.2M743.2M841.6M724.6M694.1M659.8M507.2M441.2M387.6M459.3M578.1M530.4M309.4M244.8M
OpEx % of Revenue19.96%20.09%18.06%23.42%33.3%15.15%18.44%19.09%20.28%20.85%21.05%23.15%23.95%23.47%25.25%24.62%23.7%24.93%28.22%25.23%25.74%27.85%24.89%23.1%22.02%26.28%32.77%32.18%27.8%27.18%
Selling, General & Admin594.7M556.9M510.5M493M536.7M669M686.6M528.8M468.7M489.1M468.4M698.4M511.6M661.1M705.7M699.9M752.4M742.9M717.6M700.9M636.9M633.8M564.6M470.1M411.8M468.2M511.8M470.2M271.6M214.4M
SG&A % of Revenue18.08%16.32%14.37%13.88%13.68%13.58%16.62%16.76%17.6%18.51%16.52%23.15%18.01%23.47%24.97%24.68%23.96%24.92%24.07%24.41%23.61%26.75%27.71%24.61%23.39%26.79%29.01%28.53%24.4%23.8%
Research & Development034.8M34.6M35.7M45.3M45.4M39.7M39.6M42.5M39.9M45.5M36.5M48.4M53.7M58.8M000000000000000
R&D % of Revenue-1.02%0.97%1.01%1.15%0.92%0.96%1.25%1.6%1.51%1.6%1.21%1.7%1.91%2.08%---------------
Other Operating Expenses61.6M93.9M96.6M303M724.9M31.6M35.5M-38.3M5M3.2M13.8M6.1M14.7M10M2.9M0-8.2M-2.2M124M23.7M57.2M26M-57.4M-28.9M-24.2M-8.9M66.3M60.2M37.8M30.4M
Operating Income406.7M358.6M208.8M-174.4M-434M723M585.2M690.8M198.9M433.4M459.3M294.6M314.6M313.2M243.6M247M384.6M297.6M98M277.2M252.5M200.9M252.8M232.5M239.2M116.4M174.9M163.6M113.5M102.6M
Operating Margin %12.37%10.51%5.88%-4.91%-11.06%14.68%14.16%21.89%7.47%16.4%16.19%9.77%11.07%11.12%8.62%8.71%12.25%9.98%3.29%9.65%9.36%8.48%12.4%12.17%13.59%6.66%9.91%9.93%10.2%11.39%
Operating Income Growth %13.41%71.74%219.72%59.82%-160.03%23.55%-15.29%247.31%-54.11%-5.64%55.91%-6.36%0.45%28.57%-1.38%-35.78%29.23%203.67%-64.65%9.78%25.68%-20.53%8.73%-2.8%105.5%-33.45%6.91%44.14%10.62%113.75%
EBITDA474.6M433.6M289.4M-81.9M-328.8M816.8M679.9M780.1M282.3M513.5M532.8M363.6M379M379.3M306M308.7M444M358M168.3M344.7M319.5M268.1M310.5M284.7M282.7M180M241.2M223.8M151.3M133M
EBITDA Margin %14.43%12.7%8.15%-2.31%-8.38%16.58%16.46%24.72%10.6%19.44%18.79%12.05%13.34%13.47%10.83%10.89%14.14%12.01%5.64%12%11.85%11.32%15.24%14.9%16.06%10.3%13.67%13.58%13.59%14.76%
EBITDA Growth %9.46%49.83%453.36%75.09%-140.25%20.14%-12.84%176.34%-45.02%-3.62%46.53%-4.06%-0.08%23.95%-0.87%-30.47%24.02%112.72%-51.17%7.89%19.17%-13.66%9.06%0.71%57.06%-25.37%7.77%47.92%13.76%72.06%
D&A (Non-Cash Add-back)67.9M75M80.6M92.5M105.2M93.8M94.7M89.3M83.4M80.1M73.5M69M64.4M66.1M62.4M61.7M59.4M60.4M70.3M67.5M67M67.2M57.7M52.2M43.5M63.6M66.3M60.2M37.8M30.4M
EBIT390.6M350.5M135.2M-275.2M-440M756M590.2M683.4M202.1M391M446.6M253.8M273M310.5M241.2M273.6M363.1M297.6M98M279.9M261.8M200.3M254M249.8M249M199.4M210.2M163.6M113.5M101.1M
Net Interest Income-112.6M-128.8M-158.8M-178.1M-118.1M-78.9M-80.5M-101.8M-76.4M-64.4M-54M-48.8M-47.3M-59.2M-61.8M-52.2M-43.2M-56.4M-82.2M00000000000
Interest Income0000007.6M010M10M3.9M0000-1.2M00000000000000
Interest Expense112.6M128.8M158.8M178.1M118.1M78.9M88.1M101.8M86.4M74.4M57.9M48.8M47.3M59.2M61.8M51M46.8M56.4M82.2M00000000000
Other Income/Expense-128.7M-136.9M-232.4M-278.9M-124.1M-45.9M-74.6M172M-83.2M-118.5M-63.9M-48.8M-27.1M-59.2M-61.8M-80M-43.2M-56.4M-82.2M-115.5M-106.2M-42.8M-93.8M-69.2M-76.3M-87.7M-93.9M-46.6M-51.6M-31.5M
Pretax Income278M221.7M-23.6M-453.3M-558.1M677.1M510.6M581.6M115.7M314.9M392.7M244.1M256.6M254M181.8M194.8M337.8M241.2M15.8M188.1M212.9M158.1M158.5M16.3M162.9M28.7M116.3M117M61.9M69.6M
Pretax Margin %8.45%6.5%-0.66%-12.76%-14.22%13.75%12.36%18.43%4.34%11.92%13.85%8.09%9.03%9.02%6.43%6.87%10.76%8.09%0.53%6.55%7.89%6.67%7.78%0.85%9.25%1.64%6.59%7.1%5.56%7.73%
Income Tax83.1M76.5M11.3M-73.2M-120.6M159.8M123.7M144.9M-11.9M116.6M139.4M85.4M91.2M92.8M68.6M72.9M125.4M86.6M26.7M74.7M80.2M57.7M58M59.5M61.9M13.2M43.2M47.9M24.9M30.1M
Effective Tax Rate %29.89%34.51%-47.88%16.15%21.61%23.6%24.23%24.91%-10.29%37.03%35.5%34.99%35.54%36.54%37.73%37.42%37.12%35.9%168.99%39.71%37.67%36.5%36.59%365.03%38%45.99%37.15%40.94%40.23%43.25%
Net Income103.9M145.2M-34.9M-380.1M-437.5M512.5M387.4M460.7M63.7M218.3M320.3M159.8M166.5M161.1M106.5M167.9M204.1M153.3M-10.9M113.4M132.7M100.6M100.9M103.8M82.5M15.5M73.1M63.2M36.3M39.5M
Net Margin %3.16%4.25%-0.98%-10.7%-11.15%10.41%9.38%14.6%2.39%8.26%11.29%5.3%5.86%5.72%3.77%5.92%6.5%5.14%-0.37%3.95%4.92%4.25%4.95%5.43%4.69%0.89%4.14%3.83%3.26%4.38%
Net Income Growth %-28.44%516.05%90.82%13.12%-185.37%32.29%-15.91%623.23%-70.82%-31.85%100.44%-4.02%3.35%51.27%-36.57%-17.74%33.14%1506.42%-109.61%-14.54%31.91%-0.3%-2.79%25.82%432.26%-78.8%15.66%74.1%-8.1%1680%
Net Income (Continuing)194.9M145.2M-34.9M-380.1M-437.5M517.3M386.9M436.7M127.6M198.3M246.1M137.8M145.5M159.4M113.2M121.9M212.4M154.6M-10.9M113.4M132.7M100.4M100.5M103.2M101M15.5M73.1M69.1M37M39.5M
Discontinued Operations-91M0000-3.9M1.7M23.5M020.5M68.7M30M20.7M1.7M046M-8.3M0000200K00000000
Minority Interest0000005.7M4.5M5M12.9M19.1M12.4M13.5M00000000000000000
EPS (Diluted)1.762.47-0.61-6.79-7.888.966.818.181.123.635.092.572.652.571.712.543.022.32-0.171.691.911.471.521.621.310.251.131.040.600.68
EPS Growth %-28.74%504.92%91.02%13.83%-187.95%31.57%-16.75%630.36%-69.15%-28.68%98.05%-3.02%3.11%50.29%-32.68%-15.89%30.17%1464.71%-110.06%-11.52%29.93%-3.29%-6.17%23.66%424%-77.88%8.65%73.33%-11.76%1128.74%
EPS (Basic)1.792.52-0.61-6.79-7.889.206.968.301.133.685.162.622.702.611.752.603.082.36-0.171.741.971.511.561.681.410.271.201.470.710.80
Diluted Shares Outstanding59.1M58.7M56.8M56M55.5M57.2M56.9M56.3M57.1M60.2M62M62.2M62.7M62.6M62.1M66.2M67.6M66.08M64.5M67.1M69.48M68.44M66.38M64.07M63.4M62M59.2M61M60.6M53.9M
Basic Shares Outstanding58.1M57.6M56.8M56M55.5M55.7M55.7M55.5M56.2M59.4M61.1M61.1M61.6M61.7M61M64.7M66.3M64.96M64.5M65.2M67.36M66.62M64.68M61.79M58.6M57.41M55.8M36.6M37.4M37.13M
Dividend Payout Ratio148.99%106.27%---27.9%106.14%27.02%188.38%55.11%36.4%69.65%138.62%54.5%70.8%40.44%20.87%21.79%-479.37%25.24%8.55%----8.76%19.15%20.11%24.81%

Key Metrics

Growth RegimeMixed
ProfitabilityStable
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Hawthorne segment volatility and leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Contraction Amidst Seasonal Peaks

SMG's revenue declined 3.9% year-over-year in fiscal 2026, with Q2 showing a 2.7% uptick but Q1 down 15.0%, indicating uneven demand and persistent Hawthorne weakness.

The top line remains under pressure, with the most recent quarter (Q3 2026) showing a 1.3% decline, suggesting that the core U.S. Consumer segment is stabilizing but not yet growing. The Hawthorne segment continues to drag, as wholesale cannabis oversupply reduces demand for high-end equipment. Investors should monitor whether the SMG 2.0 strategy can translate into durable revenue growth, especially given the seasonal concentration in Q2 and Q3.

Gross Margin Recovery but Structural Ceiling

Gross margin improved to 31.2% in Q3 2026 from 29.5% a year earlier, but remains below the 41.8% peak in Q2 2026, reflecting commodity cost pressures and retail pricing dynamics.

The sequential improvement from Q1's 25.0% to Q2's 41.8% highlights the seasonal leverage, but the year-over-year comparison shows only modest gains. The structural ceiling is evident when comparing to peers like Spectrum Brands (36.7%) and Central Garden & Pet (31.1%), suggesting limited pricing power. Commodity input costs (urea, resin, diesel) and the bargaining power of big-box retailers likely cap margin expansion.

Operating Leverage Amplifies Seasonal Swings

Operating margin swung from -38.7% in Q4 2025 to 28.2% in Q2 2026, demonstrating extreme operating leverage tied to fixed SG&A and seasonal revenue, with Q3 2026 at 14.5%.

The fixed cost base, particularly SG&A, does not scale down proportionally with revenue, causing deep losses in off-peak quarters. In Q3 2026, SG&A of $145.6M was only slightly below the prior year's $141.4M, while revenue declined, compressing operating margin from 18.1% to 14.5%. This suggests that cost discipline is not fully offsetting revenue softness, and any sustained demand weakness could further pressure margins.

EPS Beat Masks Underlying Revenue Weakness

Q3 2026 EPS of $1.90 beat consensus by a wide margin, but net income rose only 1.9% year-over-year, and stock-based compensation of $38.3M in the quarter raises questions about earnings quality.

The massive beat versus consensus (which expected a loss) appears driven by cost controls and possibly one-time items, not top-line strength. SBC of $38.3M in Q3 2026 is the highest in the ten quarters shown, representing about 34% of net income, which may indicate dilution pressure. Investors should scrutinize the sustainability of these earnings, especially given the persistent revenue decline and the Hawthorne segment's drag.

COGS and SG&A Discipline Under Scrutiny

COGS as a percentage of revenue improved to 68.8% in Q3 2026 from 70.5% a year earlier, but SG&A rose 3.0% year-over-year, indicating limited expense discipline despite revenue declines.

The gross margin improvement suggests some commodity cost relief or pricing actions, but SG&A growth in a declining revenue environment is concerning. In Q3 2026, SG&A increased to $145.6M from $141.4M, while revenue fell, implying that overhead is not being rightsized. This may reflect investments in the SMG 2.0 strategy, but investors should monitor whether these costs translate into future growth or simply erode margins.

Q2 2026: A Temporary Peak or New Baseline?

Q2 2026 delivered the strongest operating margin (28.2%) and EPS ($4.04) in the ten-quarter window, but the subsequent Q3 decline suggests this may be a seasonal peak rather than a sustainable trend.

The Q2 performance benefited from favorable spring weather and channel restocking, but the sharp drop to 14.5% operating margin in Q3 indicates that the company cannot sustain that level of profitability. The year-over-year revenue growth of 2.7% in Q2 was the only positive quarter in the last five, suggesting that the underlying demand environment remains weak. This inflection point highlights the cyclicality of the business and the challenges of achieving consistent growth.

What Could Invalidate the Recovery Narrative

Despite the Q3 EPS beat, revenue is still contracting, and the Hawthorne segment remains a drag; if cost discipline fades or cannabis oversupply persists, margins could compress further.

Short-sellers would point to the persistent revenue decline (-3.9% YoY) and the fact that the EPS beat was driven by cost cuts, not demand. The Hawthorne segment's fixed-cost footprint may not be fully rightsized, and any further deterioration in wholesale cannabis prices could lead to additional write-downs. Additionally, the high leverage and rising interest expenses could pressure net income if rates stay elevated. Investors should monitor whether the SMG 2.0 strategy can generate organic growth, or if the company is merely managing its way through a cyclical downturn.

SMG — Frequently Asked Questions

Quick answers to the most common questions about buying SMG stock.

What was The Scotts Miracle-Gro Company's (SMG) revenue in 2026?

For fiscal year 2026, The Scotts Miracle-Gro Company (SMG) reported total revenue of $3.29B. This represents a 265.1% increase compared to $900.8M in 1997.

Is The Scotts Miracle-Gro Company (SMG) profitable?

The Scotts Miracle-Gro Company (SMG) is profitable, generating $103.9M in net income for the fiscal year ending 2026 with a net profit margin of 3.2%.

What is The Scotts Miracle-Gro Company's operating profit margin?

The Scotts Miracle-Gro Company (SMG) reported an operating income of $406.7M, resulting in an operating profit margin of 12.4%. This margin reflects the operational efficiency of the business before interest and taxes.

What is The Scotts Miracle-Gro Company's gross profit and gross margin?

The Scotts Miracle-Gro Company (SMG) generated $1.06B in gross profit for the year, representing a gross profit margin of 32.3%. This demonstrates the company's core pricing power and production efficiency.